Bioalpha Holdings Stock

Equities

BIOHLDG

MYQ0179OO000

Pharmaceuticals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-14 pm EDT 5-day change 1st Jan Change
0.085 MYR -5.56% Intraday chart for Bioalpha Holdings 0.00% -22.73%
Sales 2021 96.72M 20.18M Sales 2022 35.8M 7.47M Capitalization 145M 30.2M
Net income 2021 -1M -209K Net income 2022 -47M -9.81M EV / Sales 2021 2.09 x
Net cash position 2021 27.98M 5.84M Net cash position 2022 36.94M 7.71M EV / Sales 2022 3.01 x
P/E ratio 2021
-171 x
P/E ratio 2022
-2.77 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 62.31%
More Fundamentals * Assessed data
Dynamic Chart
Bioalpha Holdings Berhad Announces Change of Address CI
Bioalpha Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bioalpha Holdings Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Bioalpha to Develop Agro Park in Kedah, Malaysia MT
Bioalpha Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Bioalpha Holdings Berhad Announces Redesignation of Kang Jimmi from Chairman of Remuneration Committee to Member of Remuneration Committee CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Audit Committee, Directorate Independent and Non Executive, Date of Change 04 September 2023 CI
Bioalpha Holdings Berhad Announces Redesignation of Kang Jimmi, from Member of Audit Committee to Chairman of Audit Committee, Date of Change 04 September 2023 CI
Bioalpha Holdings Berhad Appoints Haji Mohd Yazid Bin Haji Mustafa as Non Executive Chairman, Directorate Independent and Non Executive CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Nomination Committee, Directorate Independent and Non Executive, Date of Change 04 September 2023 CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Risk Committee Directorate Independent and Non Executive, Date of Change 04 September 2023 CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Non Executive Director, Directorate Independent and Non Executive, Date of Change 04 September 2023 CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Chairman of Remuneration Committee, Directorate Independent and Non Executive, Date of Change 04 September 2023 CI
Bioalpha Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Member of Risk Committee CI
More news
1 day-5.56%
1 month-5.56%
3 months-19.05%
Current year-22.73%
More quotes
1 week
0.09
Extreme 0.085
0.09
1 month
0.09
Extreme 0.085
0.10
Current year
0.09
Extreme 0.085
0.14
1 year
0.08
Extreme 0.08
0.14
3 years
0.08
Extreme 0.075
0.24
5 years
0.07
Extreme 0.065
0.40
10 years
0.07
Extreme 0.065
0.40
More quotes
Managers TitleAgeSince
Founder 48 04-12-31
Director of Finance/CFO 42 13-12-31
Chief Tech/Sci/R&D Officer 43 -
Members of the board TitleAgeSince
Founder 48 04-12-31
Director/Board Member 56 22-05-31
Director/Board Member 45 22-05-31
More insiders
Date Price Change Volume
24-04-15 0.085 -5.56% 1,408,100
24-04-12 0.09 +5.88% 1,549,400
24-04-09 0.085 0.00% 238,300

End-of-day quote BURSA MALAYSIA, April 14, 2024

More quotes
Bioalpha Holdings Berhad is a Malaysia-based integrated health supplement company. It is principally involved in agricultural development, research and development (R&D), manufacturing, distribution and marketing of functional food and health supplement products under Original Design Manufacturer (ODM) and Original Brand Manufacturer (OBM) basis, as well as operating a retail pharmacy chain under the brand Constant. Its product categories include Health Food, Health Drinks, Tea Ranges, Health supplements, Beauty@NuShine, and Herbal Farming. The Company's health supplement products comprise processed herbs, formulated ingredients, functional foods as well as herbal and non-herbal supplements that offer a variety of health benefits, including general health maintenance, improving blood circulation, enhancing vitality and general well-being. All of its health supplement products are halal-certified and are sold in Malaysia with Indonesia and China as export markets.
More about the company
  1. Stock Market
  2. Equities
  3. BIOHLDG Stock